Acute myelomonocytic leukemia, in remission digital illustration

Acute myelomonocytic leukemia, in remission Save


ICD-10 code: C92.51

Disease category: C92.5: Acute myelomonocytic leukemia

Acute Myelomonocytic Leukemia in Remission

Acute Myelomonocytic Leukemia (AML) is a type of cancer that affects the blood and bone marrow. It is a rare type of leukemia that is characterized by the presence of abnormal white blood cells known as myelomonocytes. These cells are produced in the bone marrow and normally function to fight infections. However, in AML, the myelomonocytes do not function properly and can accumulate in the bone marrow and blood, leading to a range of symptoms.

Remission is a term used to describe when the signs and symptoms of AML have disappeared. This means that there is no evidence of leukemia in the body, although it is important to note that remission is not the same as a cure. Patients with AML in remission will still need to undergo regular check-ups to monitor for any signs of the disease returning.

Remission can be achieved through a variety of treatments, including chemotherapy, radiation therapy, stem cell transplants, and targeted therapies. The specific treatment plan will depend on the individual patient and their unique circumstances.

It is important to note that achieving remission does not mean that the patient is out of the woods. Patients with AML in remission will still need to take steps to maintain their health and prevent the disease from returning. This may include maintaining a healthy diet, staying physically active, and avoiding exposure to certain environmental toxins.

  1. Regular check-ups: Patients with AML in remission will need to undergo regular check-ups to monitor for any signs of the disease returning.
  2. Maintain a healthy lifestyle: Patients should maintain a healthy diet, stay physically active, and avoid exposure to certain environmental toxins.
  3. Follow the treatment plan: Patients should follow their treatment plan as prescribed by their healthcare provider to help maintain remission and prevent the disease from returning.

In conclusion, AML in remission means that there is no evidence of leukemia in the body. Achieving remission is a significant milestone in the treatment of AML, but patients need to take steps to maintain their health and prevent the disease from returning. Regular check-ups, maintaining a healthy lifestyle, and following the treatment plan are all important steps in achieving long-term remission.

Treatment of Acute myelomonocytic leukemia, in remission:

Treatment Options for Acute Myelomonocytic Leukemia in Remission

Acute myelomonocytic leukemia (AML) is a type of cancer that affects the blood and bone marrow. If you've been diagnosed with AML and have undergone treatment, you may now be in remission. However, it's important to continue monitoring your health and working with your healthcare team to maintain your remission. Here ...

To see full information about treatment please Sign up or Log in